BigHat founder Mark DePristo spoke about “Antibody design using synthetic biology and machine learning at BigHat Biosciences” at SMI’s AI in Drug Discovery 2021 conference. Topics covered:

• An introduction to AI/ML in drug discovery
• An overview of the outstanding challenges in antibody design and engineering
• Integrating a high-speed wet lab and machine learning for antibody design and engineering
• Case studies of creating antibodies on BigHat's platform‍

Watch the talk on BigHat's YouTube channel or view the slides.

‍